129 related articles for article (PubMed ID: 38697410)
1. Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.
Guan HR; Li B; Zhang ZH; Wu HS; Wang N; Chen XF; Zhou CL; Bian XR; Li L; Xu WF; He XL; Dong YJ; Jiang NH; Su J; Lv GY; Chen SH
J Ethnopharmacol; 2024 Sep; 331():118274. PubMed ID: 38697410
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin Alleviates Inflammation, Insulin Resistance, and Reproductive Abnormalities in Mice with Polycystic Ovary Syndrome via the TLR4-NF-κB Signaling Pathway.
Liu F; Wang X; Zhao M; Zhang K; Li C; Lin H; Xu L
Discov Med; 2024 May; 36(184):946-958. PubMed ID: 38798254
[TBL] [Abstract][Full Text] [Related]
3. Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
Shen HR; Xu X; Li XL
Reprod Biol Endocrinol; 2021 Jan; 19(1):3. PubMed ID: 33407557
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
5. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
6. Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome.
Wang Y; Xiao H; Liu Y; Tong Q; Yu Y; Qi B; Bu X; Pan T; Xing Y
Front Endocrinol (Lausanne); 2022; 13():891297. PubMed ID: 36017323
[TBL] [Abstract][Full Text] [Related]
7. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
Zhu Y; Li Y; Liu M; Hu X; Zhu H
Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
[TBL] [Abstract][Full Text] [Related]
8. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
[TBL] [Abstract][Full Text] [Related]
9. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
Liu M; Zhu H; Zhu Y; Hu X
J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
11. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
12. Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment.
Wang Z; Zhai D; Zhang D; Bai L; Yao R; Yu J; Cheng W; Yu C
Reprod Sci; 2017 May; 24(5):682-690. PubMed ID: 27634381
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of Chinese medicine Bushen Huatan formula for treatment of polycystic ovary syndrome in mice via regulating gut microbiota and PPARγ pathway.
Cui M; Hong Y; Huang J; Liu K; Chen J; Tan Y; Nie X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 52(1):33-45. PubMed ID: 37283116
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
16. The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.
Ren Y; Ye Y; Xuan F; Chen A; Jin R; Zhou W; Lu J
Reprod Biol; 2023 Jun; 23(2):100763. PubMed ID: 37075562
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway.
Jiang B; Xue M; Xu D; Song Y; Zhu S
Cell Cycle; 2020 Mar; 19(6):697-710. PubMed ID: 32089069
[TBL] [Abstract][Full Text] [Related]
18. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
19. Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota.
Wang X; Gu L; Zhang Y; Xiong C; Peng Y; Ding X
Front Endocrinol (Lausanne); 2022; 13():1030151. PubMed ID: 36619569
[TBL] [Abstract][Full Text] [Related]
20. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
